"10.1371_journal.pone.0063480","plos one","2013-05-21T00:00:00Z","Tomas Kalincik; Timothy Spelman; Maria Trojano; Pierre Duquette; Guillermo Izquierdo; Pierre Grammond; Alessandra Lugaresi; Raymond Hupperts; Edgardo Cristiano; Vincent Van Pesch; Francois Grand’Maison; Daniele La Spitaleri; Maria Edite Rio; Sholmo Flechter; Celia Oreja-Guevara; Giorgio Giuliani; Aldo Savino; Maria Pia Amato; Thor Petersen; Ricardo Fernandez-Bolanos; Roberto Bergamaschi; Gerardo Iuliano; Cavit Boz; Jeannette Lechner-Scott; Norma Deri; Orla Gray; Freek Verheul; Marcela Fiol; Michael Barnett; Erik van Munster; Vetere Santiago; Fraser Moore; Mark Slee; Maria Laura Saladino; Raed Alroughani; Cameron Shaw; Krisztian Kasa; Tatjana Petkovska-Boskova; Leontien den Braber-Moerland; Joab Chapman; Eli Skromne; Joseph Herbert; Dieter Poehlau; Merrilee Needham; Elizabeth Alejandra Bacile Bacile; Walter Oleschko Arruda; Mark Paine; Bhim Singhal; Steve Vucic; Jose Antonio Cabrera-Gomez; Helmut Butzkueven; on behalf of the MSBase Study Group ¶","Departments of Medicine and Neurology, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia; Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy; Hôpital Notre Dame, Montreal, Canada; Hospital Universitario Virgen Macarena, Sevilla, Spain; Hotel-Dieu de Levis, Quebec, Canada; MS Center, Department of Neuroscience and Imaging, University G. dAnnunzio, Chieti, Italy; Maaslandziekenhuis, Sittard, The Netherlands; Hospital Italiano, Buenos Aires, Argentina; Cliniques Universitaires Saint-Luc, Brussels, Belgium; Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada; AORN San Giuseppe Moscati, Avellino, Italy; Hospital S. Joao, Porto, Portugal; Assaf Harofeh Medical Center, Beer-Yaakov, Israel; University Hospital San Carlos, IdISSC, Madrid, Spain; Ospedale di Macerata, Macerata, Italy; Consultorio Privado, Buenos Aires, Argentina; Department NEUROFARBA, Section of Neurology, University of Florence, Florence, Italy; Kommunehospitalet, Aarhus C, Denmark; Hospital Universitario Virgen de Valme, Seville, Spain; Neurological Institute IRCCS Mondino, Pavia, Italy; Ospedali Riuniti di Salerno, Salerno, Italy; Karadeniz Technical University, Trabzon, Turkey; John Hunter Hospital, Newcastle, Australia; Hospital Fernandez, Buenos Aires, Argentina; Craigavon Area Hospital, Portadown, United Kingdom; Groen Hart Ziekenhuis, Gouda, The Netherlands; FLENI, Buenos Aires, Argentina; Brain and Mind Research Institute, Sydney, Australia; Jeroen Bosch Ziekenhuis, s-Hertogenbosch, The Netherlands; HIGA Gral, San Martin La Plata, Argentina; Jewish General Hospital, McGill University, Montreal, Canada; Flinders University and Medical Centre, Adelaide, Australia; INEBA, Buenos Aires, Argentina; Amiri Hospital, Kuwait City, Kuwait; Geelong Hospital, Geelong, Australia; Jahn Ferenc Teaching Hospital, Budapest, Hungary; Clinic of Neurology Clinical Center, Skopje, Macedonia; Francicus Ziekenhuis, Roosendaal, The Netherlands; Sheba Medical Center, Tel Hashomer, Israel; Hospital Angeles Mexico City, Lomas, Mexico; New York University Hospital for Joint Diseases, New York, New York, United States of America; Multiple Sclerosis Centre Kamillus-Klinik, Asbach, Germany; Royal North Shore Hospital, Sydney, Australia; Instituto de Neurociencias Cordoba, Cordoba, Argentina; Hospital Ecoville, Curitiba, Brazil; St Vincents Hospital, Melbourne, Australia; Bombay Hospital Institute of Medical Sciences, Mumbai, India; Westmead Hospital, Sydney, Australia; Centro Internacional de Restauracion Neurologica, Havana, Cuba; Department of Neurology, Box Hill Hospital and Monash University, Melbourne, Australia","Conceived and designed the experiments: TK HB. Performed the experiments: TS BS EvM TK MT AL EC VVP FGM CO-G MPA RB G. Izquierdo FM RA HB PD G. Iuliano PG RH DLS MER SF GG AS TP RF-B CB JL-S ND OG FV MF MB VS MS MLS CS KK TP-B LdB-M JC ES JH DP MN EABB WOA MP SV JACG. Analyzed the data: TK. Wrote the paper: TK.","The authors have the following conflicts: TK received travel grants and honoraria from Novartis, Biogen Idec, Sanofi Aventis, Teva and Merck Serono. TS received travel grant from Biogen Idec. MT received honoraria from Biogen-Idec, Bayer-Schering, Sanofi Aventis, Merck-Serono, Teva and Novartis; and research grants from Biogen-Idec, Merck-Serono, and Novartis. GI received honoraria from Biogen-Idec, Novartis, Sanofi, Serono and Teva. AL is a Bayer Schering, Biogen Idec, Genzyme, Merck Serono Advisory Board Member. She received travel and research grants and honoraria from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and Teva, travel and research grants from the Associazione Italiana Sclerosi Multipla and is consultant of Fondazione Cesare Serono. EC received honoraria as scientific advisory board consultant from Biogen-Idec, Bayer-Schering, Merck-Serono, Genzyme and Novartis; has participated in research projects by Merck-Serono, Roche and Novartis. VvP has served on advisory boards for Biogen Idec and Genzyme; received travel grants from Biogen Idec, Bayer Schering, Sanofi Aventis, Merck Serono and Novartis Pharma and honoraria from Biogen Idec, Teva and Novartis Pharma. FGM received honoraria from Biogen Idec, Genzyme, Novartis and Roche. COG received honoraria as scientific advisory board consultant from Biogen-Idec, Bayer-Schering, Merck-Serono, Teva and Novartis; has participated in research projects by Biogen-Idec, GSK, Teva and Novartis. MPA received honoraria as consultant on scientific advisory boards by Biogen-Idec, Bayer-Schering, Merck-Serono, Teva and Sanofi-Aventis; has received research grants by Biogen-Idec, Bayer-Schering, Merck-Serono, Teva and Novartis. TP has recieved funding or speaker honoraria from Biogen Idec, Merck Serono, Novartis, Bayer Schering, Sanofi-Aventis, Roche, and Genzyme. RB received honoraria from Bayer Schering, Biogen, Novartis, Sanofi-Aventis, Teva; research grants from Bayer Schering, Biogen, Novartis, Sanofi-Aventis, Teva; congress and travel expense compensations from Bayer Schering, Biogen, Novartis, Sanofi-Aventis, Teva. GI had travel/accommodations/meeting expenses funded by Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis, and Teva. JLSs institution receives support from Biogen Idec, Genzyme Sanofi, Merck Serono and Novartis. FM has participated in clinical trials sponsored by EMD Serono and Novartis. RA received honororia from Biologix, Bayer, Merck Sorono, GSK and Novartis, and served on advisory board for Biologix, Novartis and Merck Sorono. HB has served on scientific advisory boards for Biogen Idec, Novartis and Sanofi-Aventis, has received travel support from Novartis, Biogen Idec and Sanofi Aventis, serves on steering committees for trials conducted by Biogen Idec and Novartis, and has received research support from Merck Serono, Novartis and Biogen Idec. PD, PG, RH, DLS, MER, SF, GG, AS, RFB, CB, ND, OG, FV, MF, MB, VS, MS, MLS, CS, KK, TPB, LdBM, JC, ES, JH, DP, MN, EABB, WOA, MP, SV and JACG did not declare any competing interests. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","Tomas Kalincik","TK",52,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
